231 large varieties, began to take the volume of procurement.

Pharmaceutical Network October 12th, a number of large varieties, with volume procurement began in the province of medicine, with volume procurement came on October 9th, Anhui Province pharmaceutical centralized procurement platform issued a notice to solicit "2020 Anhui Province public medical institutions clinical commonly used drugs centralized band procurement negotiations negotiations" opinion.
according to the content of the opinion draft, Anhui Province this volume of procurement focused on the varieties are mainly four categories of drugs, namely, clinical commonly used respiratory drugs, acid suppressants, liver and bile disease drugs and medical imaging contrast agents.
selected the top 90% of the four types of procurement of public medical institutions in the province in 2019, and selected and determined them in combination with the clinical actual organization experts.
the top 90 per cent of purchases, they cover a lot more.
, it can be predicted that the competition between enterprises, but also a fierce game.
of opinions shows that Anhui's current volume procurement is conducted by way of negotiations, the current proposed negotiation of a total of 231 drugs.
the enterprise to confirm the product finalist price agreed by experts, fill in the "negotiating shortlist price confirmation letter (registration form)."
enterprises will not accept the product negotiation if they do not accept the product shortlist price.
for enterprises to declare product decline, there are clear requirements: products based on expert argumentation included in the corresponding product competition group.
specific groups and the total number of drugs can be seen in the table below, the number of drugs in each group later according to the enterprise confirmation negotiations on the final price adjustment.
enterprises according to the decline in product declaration, fill in the "negotiating voluntary price reduction commitment letter" to determine the negotiating benchmark price.
the product negotiation benchmark price - the product negotiation finalist price × (1-declaration reduction).
From the above group situation, liver and bile disease drugs, respiratory drugs of domestic injections, respiratory drugs imported preparations, acid injections, medical imaging contrast agents of iodine-containing preparations and other groups are the most intense competition.
price big PK in accordance with the requirements of the draft opinion, to determine the negotiation enterprises and drugs, enterprises at the negotiating site to submit the "negotiating voluntary price reduction commitment letter."
Provincial Pharmaceutical Joint Procurement Office will read out on-site the decline of enterprise products, according to the number of products effectively declared in the competition group, combined with the decline in product declaration from large to small order to eliminate, determine the negotiation of drugs and enterprises.
the smallest reduction in filings, the smallest amount of products purchased online in the province in 2019 was eliminated.
is different from many places in terms of finalist negotiation rules.
the competition groups to declare the number of products less than 5, not eliminated, directly into the negotiation process.
the rest of the situation, at most, only six products were eliminated.
, the final negotiation process is different from the success of the negotiations, want to win in the volume of procurement, but also after a round of price killing.
according to the draft opinion, on the basis of negotiating the benchmark price, the finalists negotiated the product and the expert group after two rounds of negotiations to negotiate the price, the negotiation successfully formed a volume procurement negotiation price.
the purchase negotiation price is the actual supply price of the enterprise, should include taxes, distribution fees and other costs.
according to the opinions currently published, there is no clear definition of the number of winning bids and entry rules for drugs in the same group, so it is not known how many products will eventually be successfully purchased in volume.
addition, it is not clear how much the band will take, and these details should be required to wait for the official documents to be published and further notice.
of 500 varieties, which will be led by the provinces, will also be on the agenda.
recently confirmed from the authority, Guangdong will start 500 varieties of belt volume procurement work in the near future, is still studying the details.
on the eve of the National Day holiday, the Sichuan Provincial Health Insurance Bureau issued the "Announcement of the Medical Security Bureau of eight provinces and regions, including Sichuan, on the implementation of the inter-provincial alliance drug centralized belt procurement work."
eight provinces (regions) including Sichuan, Inner Mongolia, Shanxi, Liaoning, Jilin, Heilongjiang, Hainan and Tibet have decided to carry out the procurement of the inter-provincial alliance drug concentration in 2020, involving a total of 17 drugs.
Also on the eve of the National Day holiday, the Shandong Provincial People's Government also issued the "Notice on the issuance of Shandong Province drugs and high-value medical supplies centralized belt procurement implementation program", clearly from the clinical use of large, high procurement amount, more competitive drugs and high-value medical supplies, the selection of drug varieties and high-value medical supplies varieties, batch classification to carry out centralized belt procurement.
this year, the Central Committee of the Communist Party of China and the State Council issued the Opinions on Deepening the Reform of the Medical Security System, calling for deepening the reform of the centralized belt procurement system for pharmaceuticals and medical supplies.
adhere to the recruitment of one, volume price linkage, the full implementation of drugs, medical supplies centralized belt procurement.
On the basis of medical insurance payment, establish a provincial tender and procurement platform for bidding, procurement, transaction, settlement and supervision, and promote the construction of a regional and national alliance procurement mechanism to form a fully competitive, reasonably priced and standardized supply guarantee system.
can be seen, in addition to national volume procurement, provincial belt procurement, all over the alliance belt procurement, the future will be the mainstream of centralized procurement of drugs, pharmaceutical companies must focus on the focus.
.